The immunolabeling analysis of Iba-1 to assess microglia in the SN region revealed that the number of Iba-1-positive microglial cells was significantly reduced in BoNT-treated mice compared to control, PD, and PD + BoNT groups. The gene discussed is AIF1; the disease is Parkinson disease.